MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
OTCPK
0.550
+0.177
+47.57%
Closed 15:56 03/13 EDT
OPEN
0.375
PREV CLOSE
0.373
HIGH
0.560
LOW
0.375
VOLUME
14.06K
TURNOVER
6.82K
52 WEEK HIGH
3.420
52 WEEK LOW
0.310
MARKET CAP
22.43M
P/E (TTM)
-2.8321
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANEB last week (0302-0306)?
Weekly Report · 6d ago
Weekly Report: what happened at ANEB last week (0223-0227)?
Weekly Report · 03/02 09:37
Weekly Report: what happened at ANEB last week (0216-0220)?
Weekly Report · 02/23 09:36
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/19 12:05
Weekly Report: what happened at ANEB last week (0209-0213)?
Weekly Report · 02/16 09:36
Anebulo Pharmaceuticals Q2 EPS $(0.05) Beats $(0.13) Estimate
Benzinga · 02/12 21:57
Anebulo Pharmaceuticals GAAP EPS of -$0.05
Seeking Alpha · 02/12 21:49
Anebulo Pharma posts Q2 net loss of USD 2.0 million, down 20 percent
Reuters · 02/12 21:49
More
About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It is engaged in developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (ACI) and the landscape of acute cannabis-induced conditions. Its lead product candidate is selonabant, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a therapy to treat cannabis toxicity. Selonabant is orally bioavailable, rapidly absorbed, and has also been formulated for intravenous administration. Selonabant is intended to rapidly reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. It is also prioritizing the advancement of a selonabant intravenous (IV) formulation as a potential treatment for pediatric patients with cannabis-induced CNS depression.

Webull offers Anebulo Pharmaceuticals Inc stock information, including OTCPK: ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.